Gene: GAD2
Official Full Name: glutamate decarboxylase 2provided by HGNC
Gene Summary: This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Oct 2008]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA15805 | GAD2 Knockout cell line (AC16) | Human | GAD2 | 1:3-1:4 | negative | Online Inquiry |
| KOA31251 | GAD2 Knockout cell line (BEAS-2B) | Human | GAD2 | 1:3~1:4 | negative | Online Inquiry |
| KOA46672 | GAD2 Knockout cell line (U-2932) | Human | GAD2 | 1:2-1:4 | negative | Online Inquiry |
| KOA62065 | GAD2 Knockout cell line (TPC-1) | Human | GAD2 | 1:5-1:8 | negative | Online Inquiry |
| KOA77492 | GAD2 Knockout cell line (NCM460) | Human | GAD2 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.